Junli Xue

710 total citations
35 papers, 516 citations indexed

About

Junli Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junli Xue has authored 35 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Junli Xue's work include RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Junli Xue is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Junli Xue collaborates with scholars based in China, United States and Australia. Junli Xue's co-authors include Yong Zhou, Xing Jiang, Hua Wang, Xinfeng Yan, Xiaoxiao Ge, Liqiong Xue, Lei Xu, Huanhuan Yang, Wenjun Bu and Yipeng Ren and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Junli Xue

34 papers receiving 510 citations

Peers

Junli Xue
Manuela Salvucci Ireland
Qiuzhen Liu China
Boquan Wu China
Eoin McDonnell United States
Weihua Wu China
Yonggang Wang China
Shilong You China
Roman Köhl Germany
Yu Geng China
Dianne J. Beveridge Australia
Manuela Salvucci Ireland
Junli Xue
Citations per year, relative to Junli Xue Junli Xue (= 1×) peers Manuela Salvucci

Countries citing papers authored by Junli Xue

Since Specialization
Citations

This map shows the geographic impact of Junli Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junli Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junli Xue more than expected).

Fields of papers citing papers by Junli Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junli Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junli Xue. The network helps show where Junli Xue may publish in the future.

Co-authorship network of co-authors of Junli Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Junli Xue. A scholar is included among the top collaborators of Junli Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junli Xue. Junli Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hao, Weihan Li, Yuan Gao, et al.. (2025). Increased nerve density adversely affects outcome in colorectal cancer and denervation suppresses tumor growth. Journal of Translational Medicine. 23(1). 112–112. 6 indexed citations
2.
Wang, Hao, Weihan Li, Shan Zhang, et al.. (2025). MAGEA6 Engages a YY1‐Dependent Transcription to Dictate Perineural Invasion in Colorectal Cancer. Advanced Science. 12(25). e2501119–e2501119. 2 indexed citations
3.
Wang, Hao, et al.. (2025). Activated Schwann cells promote tumor growth in colon cancer. Cancer Letters. 626. 217791–217791.
4.
Wang, Hao, et al.. (2025). The gut-brain axis in the context of colorectal cancer. Pharmacological Research. 217. 107816–107816. 2 indexed citations
5.
6.
Yu, Minhao, Hao Wang, Wei Zhao, et al.. (2022). Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancer. Theranostics. 12(9). 4386–4398. 14 indexed citations
7.
Zheng, Xin Xiao, Yanbao Zhang, Xinge Cui, et al.. (2021). Development of a rapid and sensitive UPLC–MS/MS assay for simultaneous quantitation of Vorolanib and its metabolite in human plasma and application to a pharmacokinetics study. Journal of Pharmaceutical and Biomedical Analysis. 199. 114034–114034. 4 indexed citations
8.
Zhong, Wen, et al.. (2020). Knockdown of lncRNA PVT1 alleviates high glucose-induced proliferation and fibrosis in human mesangial cells by miR-23b-3p/WT1 axis. Diabetology & Metabolic Syndrome. 12(1). 33–33. 26 indexed citations
9.
Huang, Wei, et al.. (2019). Type Iγ phosphatidylinositol phosphate kinase promotes tumor growth by facilitating Warburg effect in colorectal cancer. EBioMedicine. 44. 375–386. 27 indexed citations
10.
Jiang, Xing, et al.. (2018). NEAT1 contributes to breast cancer progression through modulating miR‐448 and ZEB1. Journal of Cellular Physiology. 233(11). 8558–8566. 106 indexed citations
11.
Ren, Yipeng, et al.. (2017). Comparative and evolutionary analysis of an adapter molecule MyD88 in invertebrate metazoans. Developmental & Comparative Immunology. 76. 18–24. 10 indexed citations
12.
13.
14.
Jiang, Hong, Yun Lin, Changqing Yang, et al.. (2012). Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk. Tumor Biology. 34(2). 779–785. 2 indexed citations
15.
Omran, Ahmed, et al.. (2012). The Expression of Interleukin-1Β and MIRNA-146A in the Cerebral Cortex of Acute <em>Escherichia coli</em> Meningitis Immature Rat Model. African Journal of Infectious Diseases. 6(2). 41–7. 6 indexed citations
16.
Feng, Bo, Lei Xu, Hua Wang, et al.. (2011). Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(9). 1130–1137. 29 indexed citations
17.
Reiser, Vladimı́r, Junli Xue, P A Detmers, et al.. (2008). Multiplexed Assays by High-Content Imaging for Assessment of GPCR Activity. SLAS DISCOVERY. 13(6). 449–455. 16 indexed citations
18.
Ma, Jun, Mengge Gao, Yong‐Jie Lu, et al.. (2006). Gain of 1q25–32, 12q23–24.3, and 17q12–22 facilitates tumorigenesis and progression of human squamous cell lung cancer. The Journal of Pathology. 210(2). 205–213. 25 indexed citations
19.
Lu, Daru, et al.. (2001). A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.. PubMed. 114(1). 25–9. 7 indexed citations
20.
Xue, Junli, et al.. (1998). Antisense oligonucleotide suppression of expression of VIP receptors in diverse intestinal cells. Gastroenterology. 114. A1192–A1192. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuela Salvucci Breakdown of academic impact, for papers by Qiuzhen Liu Breakdown of academic impact, for papers by Boquan Wu Breakdown of academic impact, for papers by Eoin McDonnell Breakdown of academic impact, for papers by Weihua Wu Breakdown of academic impact, for papers by Yonggang Wang Breakdown of academic impact, for papers by Shilong You Breakdown of academic impact, for papers by Roman Köhl Breakdown of academic impact, for papers by Yu Geng Breakdown of academic impact, for papers by Dianne J. Beveridge
Rankless by CCL
2026